DEFA14A: Waystar Holding Corp. Grants Performance Stock Units to CEO and Expands Board of Directors
8-K Filing
Waystar Holding Corp. approved a performance-based stock unit grant to its CEO and plans to expand its board, pending stockholder approval.
Summary
- Waystar Holding Corp.'s Compensation Committee approved a grant of 396,197 performance stock units (PSUs) to CEO Matt Hawkins under the 2024 Equity Incentive Plan.
- The number of PSUs that vest depends on Waystar's total shareholder return (TSR) relative to the S&P SmallCap 600 Information Technology sector index over a four-year period from April 1, 2025, to April 1, 2029.
- Vesting ranges from 0% to 200% of the target PSUs based on TSR percentile ranking within the peer group.
- The company intends to expand the Board of Directors from ten to twelve members, pending stockholder approval of an amendment to the company's certificate of incorporation.
- Aashima Gupta and Michael Roman are nominated to join the board as Class III and Class I directors, respectively, contingent upon the amendment's effectiveness and Board approval.
- Both nominees have been deemed independent under Nasdaq rules and the company's Corporate Governance Guidelines.
- Ms. Gupta is nominated to the Audit & Risk Committee, and Mr. Roman to both the Audit & Risk Committee and the Nominating Committee.
Sentiment
Score: 7
Explanation: The announcement is generally positive, outlining standard corporate governance procedures and executive compensation practices. The addition of independent directors is a positive sign for corporate governance.
Positives
- The performance-based PSU grant aligns CEO compensation with shareholder value creation.
- The expansion of the Board of Directors could bring fresh perspectives and expertise.
- The nominees for the board are deemed independent, ensuring objective oversight.
- Aashima Gupta brings experience in healthcare solutions from Google Cloud and Kaiser Permanente.
- Michael Roman brings extensive leadership experience from his tenure as CEO of 3M Company.
Risks
- PSU vesting is contingent on achieving specific TSR performance targets, which may not be met.
- The expansion of the Board of Directors is subject to stockholder approval, which is not guaranteed.
- The new directors' appointments are contingent upon the effectiveness of the Certificate of Amendment and Board approval.
Future Outlook
The company intends to file the Certificate of Amendment promptly upon stockholder approval and appoint the new directors upon the amendment's effectiveness and Board approval.
Industry Context
The use of performance-based equity compensation is a common practice in the technology industry to align executive incentives with shareholder returns. Expanding the board with experienced professionals is also a typical move for companies seeking to enhance their governance and strategic oversight.
Comparison to Industry Standards
- Performance-based equity compensation is a common practice among S&P SmallCap 600 Information Technology companies, aligning executive pay with shareholder value.
- Companies like Cerner (now Oracle Health) and Allscripts Healthcare Solutions also utilize TSR-based metrics in their executive compensation plans.
- Board expansions are often seen in growing companies to bring in diverse expertise, similar to moves by companies like Veeva Systems and Teladoc Health.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Class III Director | N/A | Aashima Gupta | Contingent upon approval | Board expansion |
| Class I Director | N/A | Michael Roman | Contingent upon approval | Board expansion |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Size | Amendment to the Certificate of Incorporation to remove the existing limit on the maximum size of the Board. | Upon filing with the Secretary of State of Delaware | Allows for expansion of the Board of Directors from ten to twelve members. |
| Committee Appointment | Aashima Gupta to be appointed to the Audit & Risk Committee. | Contingent upon approval | Adds expertise to the Audit & Risk Committee. |
| Committee Appointment | Michael Roman to be appointed to both the Audit and Risk Committee and the Nominating Committee. | Contingent upon approval | Adds expertise to the Audit & Risk Committee and the Nominating Committee. |
Stakeholder Impact
- Shareholders may benefit from the alignment of CEO compensation with TSR performance.
- Employees may be impacted by the CEO's focus on achieving TSR targets.
- The expansion of the Board of Directors could lead to improved corporate governance and strategic decision-making.
Next Steps
- Obtain stockholder approval for the amendment to the Certificate of Incorporation.
- File the Certificate of Amendment with the Secretary of State of Delaware.
- Appoint Aashima Gupta and Michael Roman to the Board of Directors.
- Appoint Aashima Gupta to the Audit & Risk Committee.
- Appoint Michael Roman to the Audit & Risk Committee and the Nominating Committee.
- Certify the performance percentile ranking achieved for the PSUs.
Key Dates
| Date | Description |
|---|---|
| November 2016 | Aashima Gupta joined Google Cloud. |
| November 2018 | Aashima Gupta became Global Director, Healthcare Solutions at Google Cloud. |
| April 2021 | Michael Roman joined the board of directors of Abbott Laboratories. |
| 2022 | Aashima Gupta joined the board of directors of Neogen. |
| May 2024 | Michael Roman retired as chief executive officer from 3M Company. |
| May 9, 2025 | Compensation Committee approved PSU grant to Matt Hawkins; Nominating Committee recommended board expansion and director appointments. |
| April 1, 2025 | Start date of the four-year performance period for PSU vesting. |
| April 1, 2029 | End date of the four-year performance period for PSU vesting. |
Keywords
performance stock units, board of directors, total shareholder return, corporate governance, executive compensation, Waystar
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.